{"id":176,"date":"2021-05-17T14:41:32","date_gmt":"2021-05-17T05:41:32","guid":{"rendered":"https:\/\/www.med.osaka-u.ac.jp\/pub\/pharma2\/english\/?post_type=research-content&p=176"},"modified":"2026-03-01T13:01:19","modified_gmt":"2026-03-01T04:01:19","slug":"yakubutsu","status":"publish","type":"research-content","link":"https:\/\/www.med.osaka-u.ac.jp\/pub\/pharma2\/english\/research-content\/yakubutsu\/","title":{"rendered":"Drug Monitoring Systems"},"content":{"rendered":"\n

\u3010Outline of the Research Project<\/strong>\u3011<\/p>\n\n\n\n

\n
\n
\n

Drugs that are systemically administrated drugs via oral, intravenous, or other routes are diffused to all the organs such as brain and heart. An organ is made up of a number of \u2018small\u2019 cell groups, each of which has different properties and roles. Majority of diseases are triggered by impairment of one or some of these cell groups. To clarify the mechanisms underlying beneficial and adverse effects of drugs requires determining whether the compounds actually reach the target cell group and how their concentrations (i.e., pharmacokinetics<\/strong>) as well as reactions on cellular functions (i.e., pharmacodynamics<\/strong>) change over time. Nevertheless, these parameters have not yet been simultaneously measured in in vivo<\/em> microenvironments by any conventional techniques.<\/span><\/p>\n<\/div>\n\n\n\n

\n
\"\"
Figure 1<\/span>\u3000A needle-type diamond microsensor<\/figcaption><\/figure>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n
\n
\n
\"\"
Figure 2<\/span>\u3000A glass microelectrode<\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n

We have recently developed an advanced drug monitoring system equipped with a needle-type \u2018diamond microsensor\u2019 (Fig. 1<\/mark>) and succeeded in detecting local pharmacokinetics and pharmacodynamics of a few drugs in live anesthetized animals.  This work has been published in Nature Biomedical Engineering<\/em><\/strong> (see our Publication List below) and is conducting by our close collaboration with the group of Professor Einaga who is an engineer in Keio University and a pioneer for diamond electrodes. Our system and methodology will contribute to improvement of administration regimens in such that the drugs can react on the target cells or tissues maximumly with minimizing the adverse effects as well as accelerate safe drug development.<\/span><\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n

\u3010Experimental Procedures and Results<\/strong>\u3011<\/p>\n\n\n\n

\n
\n

Size of cell group is often less than 1 mm. Our drug monitoring system harbors two different sensors.  One is a needle-type \u2018diamond microsensor\u2019 (tip diameter: 10~40 \u00b5m, Fig. 1<\/span>), which can detect local drug concentrations over time. As compared with conventional materials for electrochemical sensors such as carbon, gold, and platinum, diamond has several advantages including a wide dynamic range detecting a variety of compound types, rapid and stable response, and low noise. The other sensor is a \u2018glass microelectrode\u2019 (tip diameter: ~1 \u00b5m, Fig. 2<\/span>), which directly measures cellular electrical activity.  Note that the electrical activity is the target for 15% of the drugs applied to patients in clinical practice. In our study, we inserted these two microsensors at the vicinity of a particular cell group in different organs and succeeded in monitoring behaviors of drugs and cellular functions \u2018simultaneously and in real time\u2019.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

Figure 3<\/span> illustrates the actions of the antiepileptic drug lamotrigine that was intravenously injected in a rat. The two microsensors were placed in the brain. As shown in the right panel, as soon as the lamotrigine concentration increased (magenta<\/em>), the neural activity was markedly suppressed (red<\/em>). Thereafter, the drug concentration was increased slowly, and 15 min after the injection the response began to decrease.<\/span><\/p>\n<\/div>\n\n\n\n

\n
\"\"
Figure 3\u3000Response of lamotrigine, an antiepileptic drug, in the rat brain<\/figcaption><\/figure>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"
Figure 4\u3000Response of bumetanide, a diuretic, in the cochlea of guinea-pig inner ear<\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n

Figure 4<\/mark> indicates the actions of bumetanide that is applicable to hypertension and epilepsy treatments but sometimes induces deafness by impairing electrical phenomenon in the inner ear. In the experiment, this diuretic was intravenously injected in a guinea pig and its pharmacokinetics and pharmacodynamics were monitored with the sensors inserted into the snail-shaped inner ear. The right panel depicts the result. Immediately after the injection the drug concentration was rapidly elevated and 1 min later it began to be reduced (green<\/em>). Simultaneously recorded electrical phenomenon (i.e., potential; red<\/em>) started to be impaired around when bumetanide concentration reached the peak. The kinetics of this drug is clearly different from that of lamotrigine shown in Figure 3<\/span>.<\/span><\/p>\n<\/div>\n<\/div>\n\n\n\n

In addition, we successfully monitored the actions of the anticancer reagent doxorubicin in vivo<\/em>.  Moreover, we found that our drug monitoring system can offer the potential to detect some antidepressants and antibiotics and other anticancer compounds in different organs. Therefore, this state-of-the-technology has a generality in the applications.<\/span><\/p>\n\n\n\n

Perspectively, this system would contribute to issues as follows.<\/p>\n\n\n\n

(1) Development of safe and effective drugs.<\/p>\n\n\n\n

(2) Proposal of administration regimens that permit the drugs to induce beneficial effects with minimal adverse actions.<\/p>\n\n\n\n

(3) Advances in drug repositioning.<\/p>\n\n\n\n

(4) Acceleration of personalized medicine.<\/p>\n\n\n\n

Recent studies using advanced technologies such as DNA microchips have revealed SNPs may at least partially account for difference in the drug actions among individuals. Furthermore, a number of researchers are working on development of drug-delivery systems that allow the chemical compounds to reach the target cells and tissues. Nonetheless, it remains uncertain how the drugs behave and their actions change in target cells or microenvironments in vivo<\/em>. This issue, which is essential for next-generation medicine, could be addressed by our technology and methodology.<\/span> <\/p>\n\n\n\n

<\/p>\n\n\n

INSTRUMENTS<\/a><\/p>\n","protected":false},"featured_media":546,"template":"","research-content_cat":[14],"class_list":["post-176","research-content","type-research-content","status-publish","has-post-thumbnail","hentry","research-content_cat-rc-main3"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/pharma2\/english\/wp-json\/wp\/v2\/research-content\/176","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/pharma2\/english\/wp-json\/wp\/v2\/research-content"}],"about":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/pharma2\/english\/wp-json\/wp\/v2\/types\/research-content"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/pharma2\/english\/wp-json\/wp\/v2\/media\/546"}],"wp:attachment":[{"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/pharma2\/english\/wp-json\/wp\/v2\/media?parent=176"}],"wp:term":[{"taxonomy":"research-content_cat","embeddable":true,"href":"https:\/\/www.med.osaka-u.ac.jp\/pub\/pharma2\/english\/wp-json\/wp\/v2\/research-content_cat?post=176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}